74
Participants
Start Date
July 16, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
BGB-R046
Intravenous administration
Tislelizumab
Intravenous administration
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
Shanghai Pulmonary Hospital, Shanghai
RECRUITING
Jinan Central Hospital, Jinan
RECRUITING
Jining No Peoples Hospital West Branch, Jining
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Guangxi Medical University Cancer Hospital, Nanning
RECRUITING
West China Hospital, Sichuan University, Chengdu
Lead Sponsor
BeiGene
INDUSTRY